American Journal of Cardiology
Volume 103, Issue 9 , Pages 1206-1209, 1 May 2009

Predicting Irreversible Left Ventricular Dysfunction After Acute Myocardial Infarction

  • Daniel R. Frisch, MD

      Affiliations

    • Division of Cardiology, Thomas Jefferson University, Philadelphia, Pennsylvania
    • Corresponding Author InformationCorresponding author: Tel: 215-955-5050; fax: 215-503-3976
  • ,
  • Evaldas Giedrimas, MD

      Affiliations

    • Division of Cardiology, Caritas St. Elizabeth's Medical Center, Boston, Massachusetts
  • ,
  • Satishkumar Mohanavelu, MS

      Affiliations

    • TIMI Study Group, Boston, Massachusetts
  • ,
  • Amy Shui, MS

      Affiliations

    • TIMI Study Group, Boston, Massachusetts
  • ,
  • Kalon K.L. Ho, MD

      Affiliations

    • Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
  • ,
  • C. Michael Gibson, MD

      Affiliations

    • Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
  • ,
  • Mark E. Josephson, MD

      Affiliations

    • Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts
  • ,
  • Peter J. Zimetbaum, MD

      Affiliations

    • Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Received 23 October 2008; received in revised form 5 January 2009; accepted 5 January 2009.

Patients with reduced left ventricular ejection fractions (LVEFs) and previous myocardial infarctions or heart failure are at increased mortality risk. Implantable cardioverter-defibrillators may mitigate this risk. The aim of this study was to identify patient characteristics at the time of presentation with ST elevation myocardial infarction (STEMI) that predict irreversible left ventricular dysfunction. From January 2003 to December 2005, patients presenting with STEMIs and an LVEFs after percutaneous coronary intervention ≤0.4 were included (n = 118). Clinical, angiographic, and electrocardiographic characteristics at the time of STEMI were evaluated to predict LVEF at ≥90 days. Multivariate analysis identified post–percutaneous coronary intervention LVEF ≤0.3 (odds ratio 5.4, 95% confidence interval 2.1 to 14.1, p = 0.001), presentation with Killip class >I (odds ratio 4.4, 95% confidence interval 1.5 to 12.6, p = 0.006), and Q waves on postrevascularization electrocardiography (odds ratio 6.3, 95% confidence interval 1.5 to 26.5, p = 0.011) to be significantly more common in the group with LVEFs ≤0.3 at ≥90 days. The presence of all 3 factors, present in 14 patients (12%), had a positive predictive value of 100% that LVEF would be ≤0.3 at ≥90 days. In conclusion, in patients with STEMIs referred for catheterization, a post–percutaneous coronary intervention LVEF ≤0.3, presentation with Killip class >I, and pathologic Q waves after revascularization each predicted that the LVEF measured at ≥90 days would remain ≤0.3. The presence of all 3 features had a positive predictive value of 100%. These findings may identify a high-risk group of patients who might benefit from early aggressive therapy such as an implantable cardioverter-defibrillator.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9149(09)00122-2

doi:10.1016/j.amjcard.2009.01.028

American Journal of Cardiology
Volume 103, Issue 9 , Pages 1206-1209, 1 May 2009